| [1] |
马彩虹,乔杰. 子宫肌瘤与不孕症相关性评估[J]. 中国实用妇科与产科杂志, 2012, 28(12): 898-901.
|
| [2] |
周蓉. 子宫肌瘤对生育力的影响及其围手术期保护[J]. 实用妇产科杂志, 2024, 40(2): 84-87.
|
| [3] |
李竹,李丽. 子宫肌瘤对女性生育能力的临床影响分析[J]. 中国性科学, 2016, 25(12): 98-101.
|
| [4] |
张凡凡. 子宫肌瘤对女性生育能力的临床影响分析[J]. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(22): 64, 67.
|
| [5] |
子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志, 2017, 52(12): 793-800.
|
| [6] |
Zhang L J, Xu F, Huang Y Y, et al. Epidemiological features of uterine fibroid-associated imaging changes in Chinese women of reproductive age: a retrospective study[J]. BMJ Open, 2025, 15(1): e085671.
|
| [7] |
Zhang Z H, Huang H X, Jiang K L, et al. Global, regional and national uterine fibroid burdens from 1990 to 2021 and projections until 2050: results from the GBD study[J]. BMC Women's Heal, 2025, 25(1): 423.
|
| [8] |
王强,李婷. 中国生育推迟的特征及其对生育水平的影响[J]. 人口学刊, 2026, 48(1): 84-98.
|
| [9] |
|
| [10] |
任艳,朱红娣,左欣,等. 冷刀宫腔镜操作系统对子宫粘膜下肌瘤切除的安全性及生育功能观察[J]. 解放军预防医学杂志, 2018, 36(12): 1564-1566.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
于朝,李文雅,王聪,等. 不影响宫腔形态的子宫肌壁间肌瘤对体外受精-胚胎移植妊娠结局的影响[J]. 中国医刊, 2025, 60(5): 592-595.
|
| [15] |
张丽霞,孙萍,张萍,等. 单发肌壁间肌瘤患者IVF/ICSI生殖结局影响因素分析[J]. 现代妇产科进展, 2024, 33(2): 120-125.
|
| [16] |
Yan L, Yu Q, Zhang Y N, et al. Effect of type 3 intramural fibroids on in vitro fertilization-intracytoplasmic sperm injection outcomes: a retrospective cohort study[J]. Fertil Steril, 2018, 109(5): 817-822.e2.
|
| [17] |
Bai X, Lin Y H, Chen Y R, et al. The impact of FIGO type 3 fibroids on in-vitro fertilization outcomes: a nested retrospective case-control study[J]. Eur J Obstet Gynecol Reprod Biol, 2020, 247: 176-180.
|
| [18] |
刘梦然,于晓兰. 国际妇产科联盟3型子宫肌瘤的临床研究进展[J]. 中国实用妇科与产科杂志, 2024, 40(2): 252-256.
|
| [19] |
Wu H B, Yang Y, Zhao C Y, et al. Preconception hypoglycemia and adverse pregnancy outcomes in Chinese women aged 20-49 years: a retrospective cohort study in China[J]. PLoS Med, 2025, 22(7): e1004667. DOI: 10.1371/journal.pmed.1004667.
|
| [20] |
Zhang Y, Zhang J H, Zhao J, et al. Couples' prepregnancy body mass index and time to pregnancy among those attempting to conceive their first pregnancy[J]. Fertil Steril, 2020, 114(5): 1067-1075.
|
| [21] |
董一飞,董徽,许建忠,等. 《中国高血压防治指南(2024年修订版)》更新要点解读[J]. 中华高血压杂志(中英文), 2025, 33(1): 14-17.
|
| [22] |
Behbehani S, Polesello S, Hasson J, et al. The effect of intramural myomas without an intracavity component on in vitro fertilization outcomes in single fresh blastocyst transfer cycles[J]. J Minim Invasive Gynecol, 2018, 25(7): 1241-1248.
|
| [23] |
Penzias A, Bendikson K, Butts S, et al. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline[J]. Fertil Steril, 2017, 108(3): 416-425.
|
| [24] |
Donnez J, Taylor H S, Marcellin L, et al. Uterine fibroid-related infertility: mechanisms and management[J]. Fertil Steril, 2024, 122(1): 31-39. DOI: 10.1016/j.fertnstert.2024.02.049.
|
| [25] |
Metwally M, Farquhar C M, Li T C. Is another meta-analysis on the effects of intramural fibroids on reproductive outcomes needed?[J]. Reprod Biomed Online, 2011, 23(1): 2-14.
|
| [26] |
Donnez J, Dolmans M M. Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review[J]. Reprod Biomed Online, 2020, 41(3): 431-442.
|
| [27] |
Rikhraj K, Tan J, Taskin O, et al. The impact of noncavity-distorting intramural fibroids on live birth rate in in vitro fertilization cycles: a systematic review and meta-analysis[J]. J Womens Health (Larchmt), 2020, 29(2): 210-219. DOI: 10.1089/jwh.2019.7813.
|